Testimonials

The people who learned before the stakes were real.

Named CEOs, physicians, institutional leaders, and advisors. Every affiliation verifiable. Below the testimonials: the transaction track record that makes the teaching credible, and the press that covered it.

Lea Ramirez — CEO, Doc1 Healthcare Systems
Lea Ramirez
CEO
Doc1 Healthcare Systems
The problems were structural, not commercial.

Chris helped me analyze the term sheet I was handed as a starting point, not a firm offer. The framework for capital markets and regulatory exposure made me realize the problems with the term sheet were structural and not commercial, reducing potential conflict in the negotiation and changing how I approached the discussion.

Term sheet negotiation
Stuart Koslick, P.Eng., MASc — CEO, Tomoverse Imaging · Professor of Practice, Department of Surgery, McGill University
Stuart Koslick, P.Eng., MASc
CEO, Tomoverse Imaging · Professor of Practice, Department of Surgery
McGill University
Exactly what the startup world has been missing.

Long before AEIOU Academy existed, Chris helped me navigate the complexity of building and scaling companies with clarity, discipline, and a level of rigor that protects founders from moving blindly or in the dark.

CEO / academic
Michael McCurdy, M.D. — Clinical Professor, University of Maryland · Founder, Sima Biomedical, Inc.
Michael McCurdy, M.D.
Clinical Professor, University of Maryland · Founder
Sima Biomedical, Inc.
I won because of what he taught me.

When I was facing a critical license negotiation and a turbulent funding round, his AEIOU guidance gave me the clarity and decision structure to break chaos into solvable moves.

Physician founder
Tamas Horvath — Bronze Star Recipient · Former Chief Quality Assurance & Accreditation Officer, United States Army
Tamas Horvath
Bronze Star Recipient · Former Chief Quality Assurance & Accreditation Officer
United States Army
This program stands out immediately.

In my career evaluating training and leadership programs across the U.S. Army and beyond, very few met the level of rigor, structure, and real-world execution I see in AEIOU.

Institutional / training evaluation
Fatma AlShehhi — Senior Credit Officer, National Bank of Ras Al Khaimah, UAE
Fatma AlShehhi
Senior Credit Officer
National Bank of Ras Al Khaimah, UAE
Rare, highly practical, and essential.

Dr. Christos’ advisory work builds disciplined judgment around risk long before it appears on a balance sheet, when it is still preventable. That capability is essential at the senior banking and board level.

Institutional / board level
Mark Johanson — CEO, Scandius Medical
Mark Johanson
CEO
Scandius Medical
Tens of millions added to our next raise.

Chris transformed how I lead in the boardroom. His AEIOU framework taught me how to manage adversarial directors, neutralize rogue behavior, and turn conflict into strategic leverage.

Advisory / governance
Tom Duquette — Former Managing Director, MedCap Funds · Board of Directors & Investment Committee Member, MedCap Funds
Tom Duquette
Former Managing Director, MedCap Funds · Board of Directors & Investment Committee Member
MedCap Funds
Codified decades of experience. Brought it to the next level.

The program codified decades of experience in healthcare investment banking and investing and brought it to the next level. Amazing classmates and instructors. I immediately shared and implemented the course into practice by sharing with my team.

Investment banking / board
Alina He 贺玉肖 — Founder & Educational Consultant, IvyStart Education
Alina He 贺玉肖
Founder & Educational Consultant
IvyStart Education
A map for entrepreneurs — the way I teach students to navigate pathways.

AEIOU gives entrepreneurs what I try to give students: visibility into the stages, decisions, and controls before the stakes are real. I came as a founder curious whether structural judgment could really be taught. It can — and the framework holds across industries and across borders.

Cross-border education founder
Internationally Recognized Instructors
The Wall Street Journal — AEIOU and Chris Velis coverage
Wall Street Journal
LSI Emerging MedTech Summit — Keynote Speaker
LSI Summit
CNBC Disruptor 50 — Auris Health (2020)
CNBC Disruptor 50
ACG New York Champion’s Award Winner
ACG Champion’s Award
MedTech Breakthrough Award
MedTech Breakthrough
Tested and Delivered Globally
Chris Velis delivering the keynote at the Chengdu Global Innovation & Entrepreneurship Fair, China
Chris Velis mentoring and judging the Harvard President’s Innovation Challenge at Harvard Innovation Labs
Chris Velis receiving recognition at UAE Innovation Week as keynote speaker for the Dubai government and Ministry of Health
Dr. Christos Kelepouris at the Acropolis, Athens, Greece
Dr. Christos Kelepouris leading international executive education in China
Dr. Christos Kelepouris teaching executive education at the U.S. Embassy in Tunisia
Chris Velis speaking to the U.S. Defense Health Agency and Walter Reed National Military Medical Center
Chris Velis on a MedTech / Biotech panel at the Wyss Institute, Harvard University, Boston
Chris Velis at the SSII Robotics public uplisting ceremony at NASDAQ
AEIOU team in Asia with Dr. Christos Kelepouris
Chris Velis meeting with Mubadala, the Abu Dhabi sovereign wealth fund, in San Francisco
Chris Velis with Bob McDonald, former Chairman and CEO of Procter & Gamble, discussing innovation
Case study

Capturing Value at Exit: The $2.35 Billion Lesson from the Auris Health / Johnson & Johnson Acquisition.

The deepest testimonial AEIOU can offer is a case study of the deals that shaped the curriculum. The Auris / J&J transaction structured $2.35 billion of asymmetric value capture through mechanism design, not contract language. Part 1 walks through what happened. Part 2 shows the structural alternative that could have been written into the paper from day one.

Written by Christopher J. Velis, who founded Auris Health and served as its founding CEO and chairman. Johnson & Johnson acquired Auris for $5.75 billion in 2019.

Read the Structural Literacy Series →
Selected transactions

$10B+ in transactions structured. 30+ deals. 5+ countries.

$5.75B
Auris Health → Johnson & Johnson
Founder, Founding CEO, Chairman · 2019
$600M
MTF Sports Medicine + CONMED
Strategic Advisor · 2018
$375M
Spine Solutions → Synthes
M&A Advisor (MedCap)
$333M
Blackstone Medical → Orthofix
M&A Advisor (MedCap)
$75M
EndoVia → Hansen Medical
M&A Advisor
$66M
Spirus → Olympus
M&A Advisor
$35M
Scandius → Covidien
M&A Advisor
$35M
Mpathy → Coloplast
M&A Advisor

Partial list. Additional closed transactions and financing rounds available on request.

In production

Additional named testimonials and video interviews with AEIOU participants are in production and will publish on a rolling basis through spring and summer 2026.

The earlier you learn this, the less it costs.

A conversation about what your program, your board, or your company needs. No pitch deck. No commitment.

Schedule a consultation →
Next cohort begins soon
Next Cohort begins June 17, 2026